Related Experiment Videos
Botulinum toxin (DYSPORT) in tension-type headaches
1Medical School of Hannover, Department of Neurology and Clinical Neurophysiology, Hannover, Germany.
Acta Neurochirurgica. Supplement
|April 27, 2002
Summary
Botulinum toxin injections did not significantly reduce tension-type headaches in this study. While both treated and placebo groups improved, further research on dosage and injection sites for botulinum toxin therapy is needed.
Area of Science:
- Neurology
- Pain Management
- Pharmacology
Background:
- Botulinum toxin type A is recognized for reducing muscle tenderness and pain in myofascial pain syndromes.
- Increased muscle tension is a potential contributing factor to tension-type headaches, suggesting botulinum toxin as a possible therapeutic agent.
Purpose of the Study:
- To investigate the therapeutic efficacy of botulinum toxin type A in patients with tension-type headaches.
- To evaluate the effect of pericranial botulinum toxin injections on headache reduction compared to placebo.
Main Methods:
- A double-blind, placebo-controlled study was conducted with 21 patients diagnosed with tension-type headaches.
- Participants received either pericranial injections of botulinum toxin (DYSPORT) or a saline placebo.
Main Results:
- No statistically significant differences in headache improvement were observed between the botulinum toxin and placebo groups at 4, 8, or 12 weeks.
- Both the verum and placebo groups demonstrated significant overall improvement in headache symptoms.
Conclusions:
- The current study suggests that the investigated dose and injection sites of botulinum toxin may not be sufficient for treating tension-type headaches.
- Higher doses or alternative injection strategies might be required. Peripheral mechanisms like pericranial muscle tension may play a limited role in the development of tension-type headaches.